Related Experiment Videos
Gene therapy in rheumatic diseases.
1Division of Clinical Immunology and Rheumatology, Department of Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, 1100 DD, The Netherlands.
Best Practice & Research. Clinical Rheumatology
|January 29, 2002
Summary
Gene therapy shows promise for treating rheumatoid arthritis (RA) by delivering therapeutic proteins to joints. While pre-clinical studies are encouraging, developing effective long-term gene expression vectors remains a key challenge for RA treatment.
Area of Science:
- Biomedical research
- Molecular medicine
- Immunology
Background:
- Rheumatoid arthritis (RA) is a chronic inflammatory joint disease causing cartilage and bone destruction.
- Understanding RA pathophysiology has spurred development of novel therapeutic strategies like gene therapy.
Purpose of the Study:
- To explore gene therapy as a novel approach for delivering therapeutic proteins to joints in arthritis patients.
- To review the application of viral and non-viral vectors for gene delivery in rheumatoid arthritis models.
Main Methods:
- Utilized various viral and non-viral vectors for ex vivo and in vivo gene delivery in animal models of RA.
- Evaluated gene transfer success and safety in RA patient joints via ex vivo gene delivery.
Main Results:
- Pre-clinical data demonstrate promising results for gene therapy strategies in RA models.
- Ex vivo gene delivery achieved successful and safe gene transfer in the joints of RA patients.
Conclusions:
- Gene therapy offers a potential new treatment avenue for rheumatoid arthritis.
- Challenges persist in developing vectors for long-term, regulated gene expression in RA therapy.